GlassScriptPhysician profile
Scott D Dreiker
NPI 1811998727
$1,376.19
in general payments reported to CMS, 2019-2025
16 companies · $259 in 2025
The $259 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $214 · 2021: $210 · 2022: $121 · 2023: $162 · 2024: $187 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $607.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $279.20 | 2020-2024 | Slynd |
| Therapeuticsmd, INC. | $177.76 | 2019-2021 | |
| Hologic Sales and Service, LLC | $176.47 | 2021-2025 | Aptima, Thinprep 2000 Processor |
| Dentsply Ih Ab | $170.90 | 2025 | Lofric |
| Abbvie INC. | $168.93 | 2019-2021 | |
| Minerva Surgical, INC | $76.24 | 2024 | |
| Agile Therapeutics, INC. | $74.40 | 2021-2023 | Twirla |
| Sage Therapeutics, LLC | $46.83 | 2025 | Zurzuvae |
| Lupin INC. | $43.20 | 2019-2020 | |
| Coopersurgical, INC. | $29.33 | 2020-2024 | Paragard T 380a |
| Ethicon US, LLC | $28.84 | 2020 | |
| Astellas Pharma US INC | $25.02 | 2024 | Veozah |
| Merck Sharp & Dohme LLC | $23.41 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $23.05 | 2021 | |
| Myovant Sciences INC. | $16.35 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $16.26 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Dreiker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.